by Kiran Singh | Jun 10, 2015 | Science |
In our last post we talked specifically about orphan drugs that are small molecules. In this post I’ll address the orphan drugs that are biologics. They behave differently: There’s a possible increase in cost/year around 2006 but it doesn’t seem to remain...
![Orphan drug prices and approvals]()
by Kiran Singh | Jun 2, 2015 | Science |
This post kicks off a series about drug prices in the orphan drug space. We initially wanted to get a sense of orphan drug price trends over the last 30 years — since the passage of the Orphan Drug Act of 1983. There were a few published industry reports...
by Kiran Singh | Apr 20, 2015 | Science |
I recently went to a conference where there was a panel discussion titled ‘Data Driven Research/Integrative Biology’. The talk was what you would expect it to be: a group of bioinformaticians fielding very vague questions regarding cultural truisms of the Data...
by Kiran Singh | Jan 23, 2015 | Science |
To cap off our Niemann-Pick C disease blog series — here are parts 1, 2, and 3 — we’ll take a closer look at the two ends of the NPC1 protein, and the roles they play in shaping how NPC1 proteins are transported from sites of production to sites of action...
